QiShenYiQi pill attenuates atherosclerosis by promoting regulatory T cells, inhibiting T helper 17 cells and accelerating cholesterol excretion

OBJECTIVE: The aim of this study was to explore potential immunoregulatory mechanisms underlying the suppressive effect on atherosclerosis of QiShenYiQi pill (QSYQ). METHODS AND RESULTS: Male ApoE(-/-) mice were maintained on a Western-type diet and QSYQ treatment for eight weeks. Determination of a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Peng, Li, Lv, Chong-Shan, Zhao, Yun, Chen, Shao-Dong, Huang, Yang, Lu, Da-Wei, Huang, Shu-Qiong, Yang, Zong-Bao, Qian, Lin-Chao, Wen, Lei
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5669882/
https://ncbi.nlm.nih.gov/pubmed/29137256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19072
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars